Hematology TimesNICE approves bosutinib for routine NHS useAugust 26, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesFDA grants drug orphan designation for CLLAugust 25, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesDrug granted breakthrough designation for BPDCNAugust 24, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesDrug no longer in development for DLBCL, other cancersAugust 16, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesFDA approves drug for prevention of CINVAugust 11, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology TimesIxazomib approved to treat rel/ref MM in CanadaAugust 9, 2016Multiple MyelomaPharmacy
Hematology TimesTeva launches generic imatinib tablets in USAugust 8, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
Hematology TimesProducts granted orphan designation for use in HSCTAugust 7, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsPharmacyTransplantation
Hematology TimesHDAC inhibitor granted breakthrough designationAugust 2, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
